Delhi HC asks CDSCO, Cipla to reply on PIL seeking to allow all Remdesivir makers to sell in domestic market

The petition has also said that huge stocks of the medicine are lying at the ports for being exported and the same can be sold in the domestic market.

Published On 2021-05-04 09:54 GMT | Update On 2021-05-04 10:06 GMT

New Delhi: The Delhi High Court Monday asked the Centre and various pharma majors to respond to a PIL seeking that all drug firms making Remdesivir, used in COVID-19 treatment, be allowed to sell it in the domestic market.

A bench of Chief Justice D N Patel and Justice Jasmeet Singh issued notice to the Health Ministry, Central Drugs Standard Control Organisation, Director General of Foreign Trade and various pharma companies, like Cipla, Zydus and Cadila, seeking their stand on the plea which claims only a handful of such firms are allowed to sell the medicine in the domestic market.

The remaining companies were involved in manufacturing the drug for export, petitioner Dincur Bajaj said, adding that since export of Remdesivir has been banned by the Centre, the companies which were producing it for export be permitted to manufacture and sell it in the domestic market.

Bajaj, who is a lawyer and the Joint Secretary of the Delhi High Court Bar Association, has claimed that there are more than 25 companies in India which manufacture the medicine, but only six to eight of them are permitted to sell it in the domestic market and the rest were producing it for exports alone.

The plea, filed through advocate Amit Saxena and Imran Ali, has said, "It is pertinent to mention that the scarcity of Remdesivir is causing its extensive black-marketing and the black marketers are charging prices up to Rs 1,00,000 per vial, due to its non-availability.

During the hearing, the central government said that the Supreme Court in its order dated April 30 has dealt with the issue of sale of essential medicines and has issued directions to the Centre in this regard.

Saxena, opposed the contention, saying the apex court's order primarily deals with sale of vaccines.

The petition has also said that huge stocks of the medicine are lying at the ports for being exported and the same can be sold in the domestic market.

Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus

2025-10-20 07:30 GMT

Delhi HC asks CDSCO, Cipla to reply on PIL seeking to allow all Remdesivir makers to sell in domestic market

The petition has also said that huge stocks of the medicine are lying at the ports for being exported and the same can be sold in the domestic market.

Similar News

Boehringer Ingelheim, AimedBio collaborate to develop ADC therapy for cancer

CDSCO Panel Rejects Pure and Cure's Empagliflozin-Based FDC, Flags Risk of UTI, Genital Mycosis

Dr. Reddy's Labs Gets CDSCO Panel Nod to Manufacture, Market Semaglutide Injection

Boston Scientific to acquire Nalu Medical for USD 533 million

AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus

Viatris buys Aculys Pharma to expand neurology portfolio in Japan

Novartis Scemblix receives positive CHMP opinion for newly diagnosed CML in adults

Strides, Incepta partner to expand women health access with WHO prequalified contraceptive